32.97
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
25.13%
226.22
|
180.79 | 162.17 | 139.92 | 152.98 |
Operating Income/Loss |
25.13%
-226.22
|
-180.79 | -162.17 | -139.92 | -152.98 |
Nonoperating Income/Loss |
48.84%
59.65
|
40.08 | - | - | - |
Income/Loss From Continuing Operations Before Tax |
18.37%
-166.57
|
-140.72 | -137.08 | -103.12 | -128.70 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.37%
-166.57
|
-140.72 | -137.08 | -103.12 | -128.70 |
|
18.37%
-166.57
|
-140.72 | -137.08 | -103.12 | -128.70 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.25%
136.03
|
135.69 | 4.4009 | 123.69 | 117.26 |
Diluted Average Shares |
0.25%
136.03
|
135.69 | 4.4009 | 123.69 | 117.26 |
Basic Earnings Per Share |
17.31%
-1.22
|
-1.04 | -1.02 | -0.83 | -1.10 |
Diluted Earnings Per Share |
17.31%
-1.22
|
-1.04 | -1.02 | -0.83 | -1.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):